Fungal strain Beauveria sp. MTCC 5184 and a process for the preparation of enzymes therefrom
US-9217140-B2 · Dec 22, 2015 · US
US11326152B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11326152-B2 |
| Application number | US-201716316458-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 14, 2017 |
| Priority date | Jul 18, 2016 |
| Publication date | May 10, 2022 |
| Grant date | May 10, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to lipase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Opening claim text (preview).
The invention claimed is: 1. A lipase variant of a parent lipase, which comprises (a) a modification at a position corresponding to position 225 of the polypeptide of SEQ ID NO: 1, wherein the modification is a deletion, an insertion of Arg, or a substitution with Arg or Lys, and (b) a modification at a position corresponding to position 231 of the polypeptide of SEQ ID NO: 1, wherein the modification is a substitution with Arg, wherein the lipase variant has at least 90% sequence identity and less than 100% sequence identity to the polypeptide of SEQ ID NO: 1 and the lipase variant has lipase activity. 2. The lipase variant of claim 1 , which has at least 95% sequence identity to the polypeptide of SEQ ID NO: 1. 3. The lipase variant of claim 1 , which has at least 97% sequence identity to the polypeptide of SEQ ID NO: 1. 4. The lipase variant of claim 1 , wherein said lipase variant further comprises one or more substitutions that correspond to substitutions in the polypeptide of SEQ ID NO: 1, selected from the group consisting of R81Q; S83T; R84H; S85T; I186L, I86P, I86V, I86W; E87A, E87I, E87K, E87T, E87V; N88Q; I90L, I90M; G91A, G91L, G91N, G91Q, G91T; N92D, N92K; L93F; N94D, N94K, N94R; F95A, F95L, F95Y; D96E, D961, D96L, D96T: L97F, L97M, L97P; K98D, K98E, K981, K98Q; and E99K. 5. The lipase variant of claim 1 , which further comprises one or more substitutions at positions corresponding to positions selected from: 27, 33, 38, 51, 56, 57, 58, 60, 69, 101, 106, 111, 131, 149, 150, 163, 198, 210, 211, 216, 220, 254, 255, 256, 263, 264, 265, 266, 267, and 269 of the polypeptide of SEQ ID NO: 1. 6. The lipase variant of claim 5 , which further comprises one or more substitutions corresponding to substitutions in the polypeptide of SEQ ID NO: 1 selected from the group consisting of: 27N, 27R; 33K, 33Q; 38A; 51I, 51L, 51V; 56K, 56Q, 56R, 56S; 57G, 57N; 58A; 60S; 69R; 101R; 106K, 106R; 111A; 131T; 149D; 150G; 163K, 163S; 198S; 210K, 210Q; 211L; 216P; 220F; 254S; 255A, 255T; 256K, 256T, 256V; 263Q; 264A, 264F, 264W; 265T; 266D; 267A; and 269N. 7. The lipase variant of claim 1 , wherein said variant comprises one-set of modifications that correspond to modifications in the polypeptide of SEQ ID NO: 1 selected from the group consisting of: N200R + G225R, S224K + G225K, S224K + G225K + L227K, S224R + G225R, S224R + G225R + L227R + V228*, S224* + G225* + T226R + L227R + V228*, S224* + G225* + T226* + L227R + V228R + V230*, S224* + G225* + T226* + L227R + P229R, G225GR, G225R + T226R, G225R + L227R, G225R + V228R, G225R + P229R, G225R + T231R, G225R + N233R, and G225* + T226* + L227R + V228R. 8. The lipase variant of claim 1 , wherein said variant has improved wash performance, a higher Benefit Risk Factor (BRF), higher relative wash performance (RP(Wash)) or lower relative odor (RP(Odor)) compared to the lipase of SEQ ID NO: 1. 9. A composition comprising the lipase variant of claim 1 and a surfactant. 10. The lipase variant of claim 1 , wherein said variant comprises a deletion or an insertion of Arg at the position corresponding to position 225 of the polypeptide of SEQ ID NO: 1. 11. The lipase variant of claim 1 , wherein said variant comprises modifications that correspond to modifications G225R+T231R in the polypeptide of SEQ ID NO: 1. 12. A method for cleaning a surface, comprising contacting the surface with the lipase variant of claim 1 . 13. A method of hydrolyzing a lipase substrate, comprising treating the lipase substrate with the lipase variant of claim 1 .
containing lipase · CPC title
Triacylglycerol lipase (3.1.1.3) · CPC title
Triglyceride splitting, e.g. by means of lipase · CPC title
Carboxylic ester hydrolases {(3.1.1)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.